Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 4851–4900 of 18639
the Company’s Board of Directors had appointed Dr Hj Mazlan Hj Bin Ahmad to serve as the Company’s Chief Executive Officer, effective immediately.
Dr. Chin Yung Kong, one of the founders and a long-time officer of the Company, had chosen to resign as Chief Executive Officer of the Company, effective immediately.
Christopher S. Sotos informed Clearway Energy, Inc. (the “Company”) on April 30, 2024 that, effective as of June 30, 2024, he will move on from his position as President and Chief Executive Officer of the Company and resign from his role as a member of the Board of Directors (the “Board”) of the Company.
Justin Earl tendered his resignation as the sole officer of the Company.
Darren López was appointed as the Chief Executive Officer of the Company.
the Board also appointed William A. Byers to serve as the Company’s Chief Financial Officer, effective as of July 22, 2024.
the following officers resigned: Daniel Jones, President, Chief Executive Officer and Chairman
the following officers resigned: Daniel Jones, President, Chief Executive Officer and Chairman, and Francis Scully, Chief Financial Officer and Security
Andrew M. Johnson as Chief Financial Officer
Sean Wallace, who served as Chief Financial Officer until Mr. Johnson’s appointment, will leave employment with the Company effective July 12, 2024.
the Company appointed Matthew Lesmeister as Chief Financial Officer
On June 18, 2024, Billy Barnard, the Interim Chief Financial Officer of flyExclusive, Inc. (the “Company”), resigned, effective immediately.
On June 19, 2024, Brianna Gerber, the Chief Financial Officer and Chief Accounting Officer of ChromaDex Corporation (the “Company”), informed the Company that she will be resigning from her roles with the Company, effective July 12, 2024 (the “Separation Date”).
Effective July 1, 2024, Mr. Guillot will return to his role as Senior Vice President – Operations and Chief Operating Officer upon the appointment of Jennifer L. Slater as President and Chief Executive Officer, as previously disclosed by the Company in its Current Report on Form 8-K filed on June 14, 2024.
On June 21, 2024, Stephen T. Worland, Ph.D., President and CEO, Michael Byrnes, Chief Financial Officer and Secretary, and Douglas Warner, M.D., Chief Medical Officer, ceased serving in their respective officer positions.
On June 21, 2024, the Board appointed Craig R. Jalbert, age 62, as the Company’s CEO, President, Treasurer and Secretary, and sole member of the Board.
On June 21, 2024, Stephen T. Worland, Ph.D., President and CEO, Michael Byrnes, Chief Financial Officer and Secretary, and Douglas Warner, M.D., Chief Medical Officer, ceased serving in their respective officer positions.
the Board of Directors had appointed John M. McCaffery as Executive Vice President and Chief Financial Officer of the Company, and its wholly owned subsidiary, Wayne Bank (the “Bank”), effective as of June 24, 2024.
Alexander J. Bruni, the Company’s Executive Vice President & Chief Financial Officer, has, at the request of the Company, resigned from his position as an officer of the Company, effective June 21, 2024.
Jonathan A. Leon, the Company’s Senior Vice President, Corporate Treasurer, has been appointed as interim Chief Financial Officer effective June 21, 2024.
Robert Ragusa Chief Executive Officer
Aaron Freidin Chief Financial Officer
the Board also announced that Christopher H. Bohnert has been appointed to fill the newly-created vacancy of Senior Vice President, Chief Financial Officer, effective as of the Transition Date.
On June 24, 2024, the Board of Directors (the “Board”) of NN, Inc. (the “Company”) announced that Michael C. Felcher, Senior Vice President, Chief Financial Officer, tendered his resignation from the Company, effective as of the close of business on June 24, 2024.
On June 24, 2024, Cohen & Steers, Inc. (the “Company”) announced the appointment of Raja Dakkuri as Executive Vice President and Chief Financial Officer of the Company, effective on such date.
As previously reported by the Company, Mr. Stadler notified the Company on October 17, 2023 of his intention to retire as Chief Financial Officer during 2024, upon the appointment of his successor. Mr. Stadler has agreed to continue with the Company in the position of Executive Vice President to assist with the transition.
Mr. Confer’s title change to President, Chief Executive Officer and Chief Financial Officer was confirmed
the Company announced that David North, the Company’s Chief Financial Officer (the “CFO”) will retire from the Company, and Laurilee Kearnes will be appointed as the Company’s new CFO
the Company announced that David North, the Company’s Chief Financial Officer (the “CFO”) will retire from the Company, and Laurilee Kearnes will be appointed as the Company’s new CFO
On June 18, 2024, Telomir Pharmaceuticals, Inc. (the “ Company ”) and Nathen Fuentes entered into a Confidential Separation and Mutual General Release Agreement (the “ Separation Agreement ”) whereby both the Company and Mr. Fuentes mutually agreed that Mr. Fuentes’ employment as a Chief Financial Officer of the Company would end as of June 18, 2024.
On June 18, 2024, the Board of the Company appointed Michelle Yanez, MBA as the Chief Financial Officer, of the Company.
On June 24, 2024, Akebia Therapeutics, Inc. (the “Company”) announced the appointment of Erik Ostrowski as the Company’s Senior Vice President, Chief Financial Officer, Chief Business Officer, Treasurer and principal financial officer, effective June 24, 2024
On June 21, 2024, Riverview Bancorp, Inc. (“Company”) announced the appointment of Nicole Sherman as President and Chief Executive Officer of the Company and its financial institution subsidiary, Riverview Bank (“Bank”) effective July 1, 2024.
In connection with Mr. Nordhagen’s departure, the Company appointed Amanda Mobley, the Company’s Director of Accounting, to serve as the Company’s Interim Chief Financial Officer, effective June 18, 2024.
On June 21, 2024, Shimmick Corporation (the “Company”) announced the departure of Devin J. Nordhagen, Chief Financial Officer, effective June 18, 2024.
the Company received a notice from Jin-Goon Kim (“Mr. Kim”), who served as the Chief Executive Officer (“CEO”), the interim Chief Financial Officer (“interim CFO”) and the chairman of the board of directors (the “Board”) of the Company, of his decision to resign as the CEO and the interim CFO of the Company, effectively immediately.
Merrick Friedman was appointed as the CFO of the Company
Vikas Desai was appointed as the CEO and a director of the Company
the Board appointed Hiroshi Nishijima, the Company’s Chief Operating Officer, as interim Chief Executive Officer.
On June 20, 2024, Greg Moran, the Company’s Chief Executive Officer, was terminated from his role.
Effective June 17, 2024, Global Gas Corporation (the “Company”) terminated its Chief Executive Officer, William Bennet Nance, Jr., for “Cause,”
On June 21, 2024, Yishay Curelaru resigned as Chief Financial Officer, Treasurer, Secretary of the Company, effective June 21, 2024, due to his continued service in the Israeli army amidst the reported hostilities and conflict in Israel.
On June 21, 2024, the Board of Directors of Ondas Holdings Inc. (the “Company”) appointed Neil Laird, Interim Chief Financial Officer (principal financial and accounting officer), Treasurer and Secretary of the Company, effective June 21, 2024.
the Company entered into a confidential separation agreement and general release with each of and Jeffrey F. Eisenberg, the Company’s former Chief Executive Officer
the Board of Directors of Xenetic Biosciences, Inc. (the “Company”) appointed James F. Parslow, the Company’s Chief Financial Officer, to the position of Interim Chief Executive Officer.
the retirement of Craig D. Gates, President and Chief Executive Officer, effective June 30, 2024.
appointed Michael Steib as President and Chief Executive Officer and as a member of the Board, effective as of August 12, 2024
promoted Sean Byrnes to Executive Vice President, Chief Financial Officer and Principal Accounting Officer of the Company and the Bank effective July 1, 2024.
Mr. Cameron succeeds Christopher D. Bohn, who was appointed to serve as the Company’s Executive Vice President and Chief Operating Officer in February 2024 and continued to serve as the Company’s Chief Financial Officer until the effective date of Mr. Cameron’s appointment.
On June 17, 2024, CF Industries Holdings, Inc. (“CF Industries” or the “Company”) announced that Gregory D. Cameron has been appointed Executive Vice President and Chief Financial Officer (principal financial officer), effective June 17, 2024.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.